BACKGROUND	Although the reduction in mortality with bivalirudin compared with unfractionated heparin plus glycoprotein IIb/IIIa inhibitors in the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction ( HORIZONS-AMI ) trial has been attributed to lower rates of major bleeding , alternative mechanisms have not been investigated in depth .\